Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Aziyo Biologics Inc Cl A (AZYO)

14.64   -0.01 (-0.07%) 03-07 03:43
Open: 14.65 Pre. Close: 14.65
High: 14.75 Low: 14.52
Volume: 14,121 Market Cap: 150M
Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo, a biological envelope that remodels into vascularized tissue for the long-term pocket protection of certain cardiac and neurostimulator implantable electronic devices; and ProxiCor, Tyke, and VasCure, which are a portfolio of extracellular matrices that retain the natural composition of collagen, growth factors, and proteins for use in vascular and cardiac repair, and pericardial closure. The company also provides FiberCel, ViBone, and OsterGro V that are viable matrices designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated human cellular dermal matrix designed to meet a range of surgical needs. In addition, it offers contract manufacturing services for various products to corporate customers. The company sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents. Aziyo Biologics, Inc. was founded in 2015 and is headquartered in Silver Spring, Maryland.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 14.846 - 14.989 14.989 - 15.075
Low: 14.213 - 14.402 14.402 - 14.516
Close: 14.424 - 14.731 14.731 - 14.916

Technical analysis

as of: 2021-03-05 5:05:20 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 18.46     One year: 19.52
Support: Support1: 14.34    Support2: 11.93
Resistance: Resistance1: 15.81    Resistance2: 16.72
Pivot: 15.42
Moving Average: MA(5): 15.00     MA(20): 15.47
MA(100): 13.65     MA(250):
MACD: MACD(12,26): -0.05     Signal(9): 0.12
Stochastic oscillator: %K(14,3): 13.71     %D(3): 24.02
RSI: RSI(14): 43.26
52-week: High: 18.20  Low: 10.55  Change(%):
Average Vol(K): 3-Month: 2621  10-Days: 1255

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
AZYO has closed above bottom band by 5.1%. Bollinger Bands are 0% narrower than normal.

Headline News

Thu, 04 Mar 2021
FY2021 EPS Estimates for Aziyo Biologics, Inc. (NASDAQ:AZYO) Lowered by Analyst - MarketBeat

Mon, 01 Mar 2021
Aziyo Biologics, Inc. (AZYO) CEO Ronald Lloyd on Q4 2020 Results - Earnings Call Transcript - Seeking Alpha

Mon, 01 Mar 2021
Edited Transcript of AZYO.OQ earnings conference call or presentation 1-Mar-21 9:30pm GMT - Yahoo Finance

Mon, 01 Mar 2021
Aziyo Biologics Reports Fourth Quarter and Full Year 2020 Financial Results - Yahoo Finance

Wed, 17 Feb 2021
Aziyo Biologics Announces First Patient Enrolled in HEAL Study - GlobeNewswire

Wed, 17 Feb 2021
Aziyo Biologics (NASDAQ:AZYO) Lowered to "Hold" at Zacks Investment Research - MarketBeat

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Underperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Underperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 7
Shares Float (M) 2
% Held by Insiders 9.02
% Held by Institutions 59.88
Shares Short (K) 154
Shares Short P. Month (K) 200

Stock Financials

EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin -45.54
Operating Margin -30.39
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth 5.7
Gross Profit (p.s.) 2.788
Sales Per Share 5.962
EBITDA (p.s.) -1.262
Qtrly Earnings Growth
Operating Cash Flow (M) -11
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales 2.45
Price to Cash Flow -9.58

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.